www.pharminvent.com November 2010 Pharmacovigilance Regulatory Science Risk Management Risk-benefit optimisation Advanced Therapies Biologics Biosimilars Generics Small molecules Centrally authorised Decentralised procedures Mutually recognised Nationally authorised
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
www.pharminvent.com November2010
Pharmacovigilance
Regulatory Science
Risk Management
Risk-benefit optimisation
Advanced Therapies
Biologics
Biosimilars
Generics
Small molecules
Centrally authorised
Decentralised procedures
Mutually recognised
Nationally authorised
www.pharminvent.com November2010
PharmInvent is led by experienced
EU ex-regulators, including former
members of CHMP and PhVWP, EMA
managers, as well as ICH and CIOMS
expert group members.
Related Documents
